Prognostic impact of galectin-3 in chronic kidney disease patients: a systematic review and meta-analysis
ConclusionsOur meta-analysis suggests that high levels of galectin-3 may increase the risk of all-cause mortality and CV events in CKD patients, however, probably not a sensitive biomarker for outcomes in HD patients. Further studies were warranted to validate our findings.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Databases & Libraries | Dialysis | Heart | Statistics | Study | Urology & Nephrology